Skip to content

Search Results

No Matching Results

    Recently Viewed

      Listening...

      HomeLatest newsJohnson & Johnson named to the TIME100 Most Influential Companies list
      lede-new-credo-2.jpg

      Johnson & Johnson named to the TIME100 Most Influential Companies list

      The company is honored to be recognized for its leadership in helping shape the trajectory of healthcare around the world.

      Share Article
      share to

      Today, Time chose Johnson & Johnson for inclusion on its first-ever list of TIME100 Most Influential Companies. An extension of the publication’s annual TIME100 list of the world’s most influential people, the new list singles out 100 companies that are positively impacting the world.

      To curate the international list, Time tapped industry experts, as well as its own editors and correspondents around the world, for nominations in every sector—from healthcare and entertainment to technology and transportation. The publication’s editors then evaluated the influence of each company not on the basis of size or scale, but with an eye on relevance, impact, innovation, leadership and success, among other key factors.

      It’s factors like these that guide decision-making at Johnson & Johnson every day, and have been at the heart of the company since its founding in 1886.

      “At a time where the stakes of good health have never been higher, this TIME100 Companies award spotlights the full impact of our work at Johnson & Johnson,” says Alex Gorsky, Johnson & Johnson’s Chairman and CEO. “From the deployment of our Janssen COVID-19 Vaccine to our continued, relentless commitment to innovation, I couldn’t be more proud of how we’re improving the lives of people all around the world.”

      When COVID-19 hit, Johnson & Johnson was able to respond to the once-in-a-lifetime challenge by harnessing its capabilities, scientific expertise, global partnerships and experience helping fight pandemics for over a century.

      When COVID-19 hit, Johnson & Johnson was able to respond to the once-in-a-lifetime challenge by harnessing its capabilities, scientific expertise, global partnerships and experience helping fight pandemics for over a century.

      And Johnson & Johnson is equally focused on addressing a range of evolving needs of patients, consumers and healthcare providers. That includes a commitment to helping eradicate racial and social injustice as a public health threat by helping to eliminate health inequities for people of color; helping expand access to medicine for multidrug-resistant tuberculosis, a hard-to-treat form of the disease; working to make clinical trials more accessible to patients; and using the company’s innovative packaging and harnessing cutting-edge technologies to ensure that all of Johnson & Johnson Consumer Health brands will use 100% recyclable, reusable or compostable plastic packaging by the year 2025.

      That ethos provides the foundation for Our Credo, the company’s guiding mission statement crafted by Robert Wood Johnson, a member of Johnson & Johnson’s founding family, in 1943. Our Credo compels everyone who works at Johnson & Johnson to put the needs and well-being of people who depend on its products and services first.

      Johnson & Johnson is proud to be recognized for the work we do by being included among the TIME100 Most Influential Companies.

      More from Johnson & Johnson

      Inside the development of a revolutionary treatment for blood cancers

      In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.

      “Lung cancer wasn’t even on my radar. Then I was diagnosed.”

      The disease is often detected late—which can have fatal consequences. But thanks to innovations in diagnostic tools, there’s a way to catch lung cancer earlier. Here’s how early detection saved one woman’s life.

      “I’m a scientist dedicated to bringing eye-health innovations to the world”

      Meet Xiao-Yu Song, Global Head of Research & Development for Vision at Johnson & Johnson, who leads a talented team that creates cutting-edge products addressing vision problems through all stages of life.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.